SparingVision Conference Participation in H2 2023

SparingVision Conference Participation in H2 2023

Paris, September 7, 2023 – SparingVision (“the Company”), a clinical-stage genomic medicine company developing vision-saving treatments for ocular diseases, today announces upcoming conferences that its management team will be participating in in the second half of 2023:


Investor and Industry Conferences:

Morgan Stanley 21st Annual Healthcare Conference, New York City, New York, US – 11-14 September

Sachs 23rd Annual Biotech in Europe Forum, Basel, Switzerland – 20-21 September

Chardan’s 7th Annual Genetic Medicines Conference, New York City New York, US – 2-3 October

Cell and Gene Meeting on the Mesa, Carlsbad, California, US – 10-12 October

Jefferies London Healthcare Conference, London, UK – 14-15 November


Scientific, Medical & Regulatory Conferences:

Johns Hopkins Retinal Degenerations and Clinical Electrophysiology Conference 2023, Baltimore, Maryland, US – 15-16 September

4th Annual Gene Therapy for Ophthalmic Disorders Conference, Boston, Massachusetts US – 3-5 October

EURETINA (European Society of Retina Specialists) Congress, Amsterdam, Netherlands – 5-8 October

2023 TOPRA Annual Symposium, Lisbon, Portugal – 23-25 October

RD 2023, Torremolinos, Spain – 23-28 October

ESGCT (European Society of Gene and Cell Therapy) 30th Annual Congress, Brussels, Belgium – 24-27 October

Eyecelerator @ AAO, San Francisco, California, US – 2 November

American College of Toxicology Annual Meeting, Orlando, Florida, US – 12-15 November

Ophthalmic Drugs, London, UK – 20-21 November